Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
STOCKS
Axovant shares crater as CEO and President both resign
By Armie Margaret Lee
Feb 12, 2018 10:18 AM EST
PRESS RELEASES
United Therapeutics Announces New England Journal Of Medicine Publication Of The INCREASE Study Evaluating Tyvaso® In Pulmonary Hypertension Associated With Interstitial Lung Disease
By PR Newswire
Jan 13, 2021 5:01 PM EST
PRESS RELEASES
United Therapeutics Announces Agreement To Acquire Priority Review Voucher
By PR Newswire
Dec 28, 2020 6:00 AM EST
PRESS RELEASES
United Therapeutics Releases Its First Corporate Responsibility Report
By PR Newswire
Nov 24, 2020 6:00 AM EST
PRESS RELEASES
United Therapeutics Corporation To Present At The Jefferies Virtual London Healthcare Conference
By PR Newswire
Nov 10, 2020 6:00 AM EST
PRESS RELEASES
United Therapeutics Corporation To Present At The Credit Suisse 29th Annual Virtual Healthcare Conference
By PR Newswire
Nov 2, 2020 5:55 AM EST
PRESS RELEASES
United Therapeutics Corporation To Report Third Quarter 2020 Financial Results Before The Market Opens On Wednesday, October 28, 2020
By PR Newswire
Oct 21, 2020 6:00 AM EDT
PRESS RELEASES
United Therapeutics To Present New Tyvaso® Clinical And Treprostinil Real-World Data At CHEST Annual Meeting 2020
By PR Newswire
Oct 15, 2020 6:00 AM EDT
PRESS RELEASES
CollPlant And United Therapeutics Announce Exercise Of Option That Will Expand Their Collaboration To Include 3D Bioprinting Of Human Kidneys For Transplant
By PR Newswire
Sep 21, 2020 7:00 AM EDT
PRESS RELEASES
United Therapeutics Corporation To Present At The Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
By PR Newswire
Sep 16, 2020 6:00 AM EDT
PRESS RELEASES
United Therapeutics Corporation Appoints Linda Maxwell To Its Board Of Directors
By PR Newswire
Sep 11, 2020 6:00 AM EDT
PRESS RELEASES
United Therapeutics Announces U.S. FDA Filing Acceptance Of Supplemental New Drug Application For Tyvaso® For Pulmonary Hypertension Associated With Interstitial Lung Disease
By PR Newswire
Aug 17, 2020 6:00 AM EDT
PRESS RELEASES
United Therapeutics Corporation To Present At The Wedbush PacGrow Healthcare Virtual Conference
By PR Newswire
Aug 5, 2020 6:00 AM EDT
PRESS RELEASES
United Therapeutics Corporation Asserts New Tyvaso Patent Against Liquidia
By PR Newswire
Jul 23, 2020 6:00 AM EDT
PRESS RELEASES
United Therapeutics Corporation To Report Second Quarter 2020 Financial Results Before The Market Opens On Wednesday, July 29, 2020
By PR Newswire
Jul 22, 2020 6:00 AM EDT
PRESS RELEASES
United Therapeutics Announces Increase Data Presentation At An American Thoracic Society Virtual Session
By PR Newswire
Jun 17, 2020 6:00 AM EDT
PRESS RELEASES
United Therapeutics Corporation Files Lawsuit Against Liquidia For Infringement Of Tyvaso Patents
By PR Newswire
Jun 5, 2020 6:00 AM EDT
PRESS RELEASES
United Therapeutics Corporation To Present At The Jefferies Virtual Health Care Conference
By PR Newswire
May 26, 2020 6:00 AM EDT
PRESS RELEASES
United Therapeutics Corporation To Present At The BofA Securities Virtual Health Care Conference 2020
By PR Newswire
May 6, 2020 6:00 AM EDT
PRESS RELEASES
United Therapeutics Corporation To Report First Quarter 2020 Financial Results Before The Market Opens On Wednesday, April 29, 2020
By PR Newswire
Apr 22, 2020 6:00 AM EDT
PRESS RELEASES
United Therapeutics Corporation To Present At The 40th Annual Cowen And Company Healthcare Conference
By PR Newswire
Feb 25, 2020 6:00 AM EST
PRESS RELEASES
United Therapeutics And DEKA Announce Additional FDA Clearance Related To The Unity Subcutaneous Delivery System For Remodulin®
By PR Newswire
Feb 24, 2020 6:16 AM EST
PRESS RELEASES
United Therapeutics Corporation To Report Fourth Quarter And Full Year 2019 Financial Results Before The Market Opens On Wednesday, February 26, 2020
By PR Newswire
Feb 19, 2020 6:00 AM EST
PRESS RELEASES
United Therapeutics Defeats Preliminary Injunction Motion In Litigation With Sandoz And RareGen
By PR Newswire
Feb 4, 2020 5:00 PM EST
PRESS RELEASES
United Therapeutics Corporation To Present At The 38th Annual J.P. Morgan Healthcare Conference
By PR Newswire
Jan 6, 2020 6:00 AM EST
